1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > China Hospital Development and Investment Report, 2014-2017

China Hospital Development and Investment Report, 2014-2017

  • August 2014
  • -
  • Research In China
  • -
  • 157 pages

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6% in 2011-2013, higher than 2.26% in 2005-2010. The revenue of China hospital industry jumped at a CAGR of 23.6% in 2011-2013, and it is expected to maintain the growth rate of over 20% and hit RMB4.07 trillion in 2017.

At the same time, various social capital flows to the Chinese hospital market by self-establishment, mergers and acquisitions (including participation in the restructuring of public hospitals), joint ventures, associates and other forms, which boosts the expansion of private hospitals. As of the end of 2013, Chinese private hospitals had accounted for 45.8% of the total Chinese hospitals, increasing by 24.5 percentage points compared with 2006. However, from the point of view of revenue structure, public hospitals still took a dominant position with the proportion of over 90%, but the figure shows a decreasing trend now.

In the private hospital investment boom, specialized hospitals involved with small investment, high returns and strong market demand have become a hotspot for social capital. Currently, the proportion of Chinese specialized hospitals in private hospitals reaches about 65%. Specialized hospitals in huge demand, such as dental hospitals, ophthalmic hospitals, plastic surgery & cosmetic hospitals, even achieve the profit margins of more than 10%, much higher than the overall level of Chinese hospitals (about 5%).

The enterprises focusing on medicine, including Shanghai Fosun Pharmaceutical, Jinling Pharmaceutical, Inner Mongolia Furui Medical Science, Wuhan Jianmin Pharmaceutical, Yibai Pharmaceutical, China Resources Sanjiu and Kangmei Pharmaceutical, are actively extending to downstream medical services. Shanghai Fosun Pharmaceutical has stepped in obstetrics & gynecology, tumor and other areas through mergers and acquisitions; its revenue from hospital medical services reached RMB474.6 million in 2013, representing a substantial increase of 215.6% over previous year.

Targeting medium and high-end medical markets, foreign-funded enterprises mainly adopt cooperative operation, equity participation, joint ventures (under the lead of foreign investors) and other approaches to develop business in China, such as Chindex United Family Hospital and Parkway Pantai. United Family Hospital had covered Beijing, Shanghai, Wuxi, Guangzhou and Tianjin by the end of June 2014, and its hospitals in Qingdao and Guangzhou are under construction.

The report highlights the followings:
China hospital industry market overview: number of hospitals of all sorts, operation, status quo of medical service, competition pattern, etc.
Current development of specialized hospitals in China: overall operation, operation of ophthalmic hospitals, dental hospitals, plastic surgery hospitals, cosmetic hospitals, obstetrics and gynecology hospitals, Children’s hospitals, and tumor hospitals as well as their development outlook;
Development prediction of China hospital industry: status quo of China medical security, influence of urbanization enhancement on China healthcare market, supply and demand of medical resources;
Investment in China hospital industry: related polices on social capital flowing into the hospital industry, operational efficiency comparison between Private hospitals and public ones, investment opportunities of specialized hospitals and public hospitals, business mode of foreign-funded hospitals in China;
Operation, investment, mergers & acquisitions, medical services and development prediction of 17 companies involved in the Chinese hospital market.

Table Of Contents

China Hospital Development and Investment Report, 2014-2017
1. Overview of China Hospital Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Overview of China Hospital Market
2.1 Number of Hospitals
2.1.1 Number of Hospitals Grows Steadily
2.1.2 Private Hospitals Show Faster Growth Rate
2.1.3 Distinct Regional Distribution of Hospitals
2.2 Revenue
2.2.1 Total Revenue Surges Rapidly
2.2.2 Revenue of General Hospitals Occupies Lion's Share
2.2.3 Proportion of Revenue from Medicine of General Hospitals on a Slow Decline
2.3 Profit
2.3.1 Profit Margin Recovers
2.3.2 Gross Margin of Specialized Hospitals Records the Highest
2.4 Medical Service
2.4.1 Severely Uneven Distribution of Medical Resources
2.4.2 Insufficient Medical Personal Impacts the Growth of Hospital Industry
2.5 Competition Pattern

3. Current Development of Specialized Hospitals in China
3.1 Operation
3.1.1 Proportion of Private Specialized Hospitals Continues to Rise
3.1.2 Revenue Generated by Specialized Hospitals Sees Rapid Growth
3.1.3 Specialized Hospitals Differ Dramatically in Profit Margin
3.2 Status Quo of Various Specialized Hospitals
3.2.1 Ophthalmic Hospitals
3.2.2 Dental Hospitals
3.2.3 Plastic Surgery and Cosmetic Hospitals
3.2.4 Obstetrics and Gynecology Hospitals
3.2.5 Children's Hospitals
3.2.6 Tumor Hospitals

4. Development Forecast of China Hospital Industry
4.1 Status Quo of China Medical Insurance
4.1.1 Medical Insurance System
4.1.2 Medical Insurance Nearly Realizes 100% Coverage
4.1.3 Medical Insurance for Serious Illness of Urban and Rural Residents
4.2 Urbanization Bolsters Development of the Hospital Industry
4.2.1 Status Quo of Urbanization in China
4.2.2 Urbanization Expects to Optimize Medical Insurance System
4.2.3 Trans-regional Medical Insurance Settlement is Promoted Soundly
4.2.4 Urbanization Incrementation Depends on the Contribution of Medical Insurance System
4.2.5 Medical Insurance Fund Balance Rate Will See Further Decrease
4.2.6 Medical Resource Supply of County-Level Hospitals Will Improve
4.2.7 Urbanization Will Encourage Central Government to Invest in Urban Medical Resources

5. Investment in China Hospital Industry
5.1 Policy Environment Becomes Warm
5.2 Comparison between Public Hospitals and Private Hospitals
5.2.1 Public Hospitals Occupy a Dominant Position
5.2.2 Private Hospitals See Higher Efficiency of Operation
5.3 Investment Opportunities of Social Capital
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals
5.4 Development Direction and Operation Mode of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China
5.4.2 Development Direction of Foreign Hospitals
5.4.3 Operation Mode of Foreign Hospitals

6 Major Chinese Enterprises
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Medical Services
6.1.6 Prediction
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Medical Services
6.2.6 Prediction
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 Medical Services
6.3.6 Prediction
6.4 Shanghai Fosun Pharmaceutical
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 RandD and Investment
6.4.6 Medical Services
6.4.7 Prediction
6.5 Jinling Pharmaceutical
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 Medical Services
6.5.6 Prediction
6.6 Shinva Medical
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 Medical Services
6.6.6 Prediction
6.7 Xi'an Kaiyuan Investment
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.5 Medical Services
6.7.6 Prediction
6.8 Inner Mongolia Furui Medical Science
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Gross Margin
6.8.5 Medical Services
6.8.6 Prediction
6.9 Wuhan Jianmin Pharmaceutical
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Gross Margin
6.9.5 Medical Services
6.9.6 Prediction
6.10 CMS Holdings Ltd.
6.10.1 Profile
6.10.2 Operation
6.10.3 Revenue Structure
6.10.4 Gross Margin
6.10.5 Medical Services
6.11 United Family Hospital
6.11.1 Profile
6.11.2 Operation
6.11.3 Medical Services
6.12 Parkway Pantai
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Services
6.13 Phoenix Healthcare
6.13.1 Profile
6.13.2 Operation
6.13.3 Medical Services
6.14 Yibai Pharmaceutical
6.14.1 Profile
6.14.2 Operation
6.14.3 Medical Services
6.15 China Resources Sanjiu
6.15.1 Profile
6.15.2 Operation
6.15.3 Medical Services
6.16 Kangmei Pharmaceutical
6.16.1 Profile
6.16.2 Operation
6.16.3 Medical Services
6.17 Jiangnan Mould and Plastic Technology
6.17.1 Profile
6.17.2 Operation
6.17.3 Medical Services

7 Summary and Forecast
7.1 Summary
7.2 Forecast

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.